Quality of life six months after myocardial infarction treated with thrombolytic therapy
暂无分享,去创建一个
To assess and compare quality of life of patients six months after an acute myocardial infarction treated with one of two thrombolytic agents, streptokinase (SK) or recombinant tissue plasminogen activator (tPA).